Loading company…
Chenghui Medical develops and sells molecular diagnostic instruments and reagents.
Founded in 2022 and based in Shenzhen, China, Chenghui Medical develops automated nucleic acid detection systems and reagents using microfluidics. Its point-of-care testing platform performs extraction and QPCR reactions in enclosed centrifugal microfluidic chips for clinical diagnosis and epidemic prevention. In February 2026, the company closed Series B+ funding from Dongguan Biotechnology Industry Development Fund to support R&D.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in